Quote | Orphazyme A/S (OTCMKTS:ORPHY)
Last: | $0.731 |
---|---|
Change Percent: | -14.0% |
Open: | $0.85 |
Close: | $0.731 |
High: | $0.9 |
Low: | $0.6925 |
Volume: | 713,744 |
Last Trade Date Time: | 03/31/2022 04:53:28 pm |
News | Orphazyme A/S (OTCMKTS:ORPHY)
2024-03-12 14:42:36 ET More on Zevra Therapeutics Zevra Therapeutics appoints Adrian Quartel as CMO Zevra seeks FDA nod for rare disease therapy arimoclomol Seeking Alpha’s Quant Rating on Zevra Therapeutics Historical earnings data for Zevra Therapeut...
2024-01-12 07:44:58 ET More on LadRx, XOMA, etc. XOMA Preferreds: I Upped My Rating On One Preferred Stock To A Buy Xoma appoints Owen Hughes as CEO, Jack Wyszomierski as chairman XOMA gets $5M milestone upon FDA's acceptance of Day One's Tovorafenib NDA Fina...
Message Board Posts | Orphazyme A/S (OTCMKTS:ORPHY)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |